The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nucleic Acid Based Gene Therapy Market Research Report 2025

Global Nucleic Acid Based Gene Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1683969

No of Pages : 87

Ask Your Query
Synopsis
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
The global Nucleic Acid Based Gene Therapy market was valued at US$ 4542 million in 2023 and is anticipated to reach US$ 8746.2 million by 2030, witnessing a CAGR of 9.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Based Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Based Gene Therapy.
Report Scope
The Nucleic Acid Based Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Based Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Based Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wave Life Sciences
Imugene
Sarepta Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Moderna
BioNTech
Nutcracker Therapeutics
Deep Genomics
Sirnaomics
Laronde
Abogen Biosciences
Segment by Type
Anti-Sence and Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Others
Segment by Application
Hospitals and Clinics
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Based Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-Sence and Anti-Gene
1.2.3 Short Inhibitory Sequences
1.2.4 Gene Transfer Therapy
1.2.5 Nucleoside Analogs
1.2.6 Ribozymes
1.2.7 Aptamers
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nucleic Acid Based Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Academic and Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Based Gene Therapy Market Perspective (2019-2030)
2.2 Nucleic Acid Based Gene Therapy Growth Trends by Region
2.2.1 Global Nucleic Acid Based Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nucleic Acid Based Gene Therapy Historic Market Size by Region (2019-2024)
2.2.3 Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2025-2030)
2.3 Nucleic Acid Based Gene Therapy Market Dynamics
2.3.1 Nucleic Acid Based Gene Therapy Industry Trends
2.3.2 Nucleic Acid Based Gene Therapy Market Drivers
2.3.3 Nucleic Acid Based Gene Therapy Market Challenges
2.3.4 Nucleic Acid Based Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue
3.1.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue (2019-2024)
3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Based Gene Therapy Revenue
3.4 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio
3.4.1 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Based Gene Therapy Revenue in 2023
3.5 Nucleic Acid Based Gene Therapy Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Based Gene Therapy Product Solution and Service
3.7 Date of Enter into Nucleic Acid Based Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Based Gene Therapy Breakdown Data by Type
4.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Type (2019-2024)
4.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2025-2030)
5 Nucleic Acid Based Gene Therapy Breakdown Data by Application
5.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Application (2019-2024)
5.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid Based Gene Therapy Market Size (2019-2030)
6.2 North America Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024)
6.4 North America Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Based Gene Therapy Market Size (2019-2030)
7.2 Europe Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024)
7.4 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (2019-2030)
8.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Based Gene Therapy Market Size (2019-2030)
9.2 Latin America Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024)
9.4 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size (2019-2030)
10.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Detail
11.1.2 Wave Life Sciences Business Overview
11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Introduction
11.1.4 Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.1.5 Wave Life Sciences Recent Development
11.2 Imugene
11.2.1 Imugene Company Detail
11.2.2 Imugene Business Overview
11.2.3 Imugene Nucleic Acid Based Gene Therapy Introduction
11.2.4 Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.2.5 Imugene Recent Development
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Detail
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.3.4 Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.3.5 Sarepta Therapeutics Recent Development
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Detail
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.4.5 Alnylam Pharmaceuticals Recent Development
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Detail
11.5.2 Ionis Pharmaceuticals Business Overview
11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.5.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.5.5 Ionis Pharmaceuticals Recent Development
11.6 Moderna
11.6.1 Moderna Company Detail
11.6.2 Moderna Business Overview
11.6.3 Moderna Nucleic Acid Based Gene Therapy Introduction
11.6.4 Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.6.5 Moderna Recent Development
11.7 BioNTech
11.7.1 BioNTech Company Detail
11.7.2 BioNTech Business Overview
11.7.3 BioNTech Nucleic Acid Based Gene Therapy Introduction
11.7.4 BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.7.5 BioNTech Recent Development
11.8 Nutcracker Therapeutics
11.8.1 Nutcracker Therapeutics Company Detail
11.8.2 Nutcracker Therapeutics Business Overview
11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.8.4 Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.8.5 Nutcracker Therapeutics Recent Development
11.9 Deep Genomics
11.9.1 Deep Genomics Company Detail
11.9.2 Deep Genomics Business Overview
11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Introduction
11.9.4 Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.9.5 Deep Genomics Recent Development
11.10 Sirnaomics
11.10.1 Sirnaomics Company Detail
11.10.2 Sirnaomics Business Overview
11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Introduction
11.10.4 Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.10.5 Sirnaomics Recent Development
11.11 Laronde
11.11.1 Laronde Company Detail
11.11.2 Laronde Business Overview
11.11.3 Laronde Nucleic Acid Based Gene Therapy Introduction
11.11.4 Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.11.5 Laronde Recent Development
11.12 Abogen Biosciences
11.12.1 Abogen Biosciences Company Detail
11.12.2 Abogen Biosciences Business Overview
11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Introduction
11.12.4 Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024)
11.12.5 Abogen Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anti-Sence and Anti-Gene
Table 3. Key Players of Short Inhibitory Sequences
Table 4. Key Players of Gene Transfer Therapy
Table 5. Key Players of Nucleoside Analogs
Table 6. Key Players of Ribozymes
Table 7. Key Players of Aptamers
Table 8. Key Players of Others
Table 9. Global Nucleic Acid Based Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Nucleic Acid Based Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Nucleic Acid Based Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Nucleic Acid Based Gene Therapy Market Share by Region (2019-2024)
Table 13. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Nucleic Acid Based Gene Therapy Market Share by Region (2025-2030)
Table 15. Nucleic Acid Based Gene Therapy Market Trends
Table 16. Nucleic Acid Based Gene Therapy Market Drivers
Table 17. Nucleic Acid Based Gene Therapy Market Challenges
Table 18. Nucleic Acid Based Gene Therapy Market Restraints
Table 19. Global Nucleic Acid Based Gene Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Nucleic Acid Based Gene Therapy Market Share by Players (2019-2024)
Table 21. Global Top Nucleic Acid Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2023)
Table 22. Ranking of Global Top Nucleic Acid Based Gene Therapy Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Nucleic Acid Based Gene Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Nucleic Acid Based Gene Therapy Product Solution and Service
Table 26. Date of Enter into Nucleic Acid Based Gene Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nucleic Acid Based Gene Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2019-2024)
Table 30. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2025-2030)
Table 32. Global Nucleic Acid Based Gene Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Application (2019-2024)
Table 34. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Application (2025-2030)
Table 36. North America Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 51. Wave Life Sciences Company Detail
Table 52. Wave Life Sciences Business Overview
Table 53. Wave Life Sciences Nucleic Acid Based Gene Therapy Product
Table 54. Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 55. Wave Life Sciences Recent Development
Table 56. Imugene Company Detail
Table 57. Imugene Business Overview
Table 58. Imugene Nucleic Acid Based Gene Therapy Product
Table 59. Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 60. Imugene Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product
Table 64. Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product
Table 69. Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Ionis Pharmaceuticals Company Detail
Table 72. Ionis Pharmaceuticals Business Overview
Table 73. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product
Table 74. Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 75. Ionis Pharmaceuticals Recent Development
Table 76. Moderna Company Detail
Table 77. Moderna Business Overview
Table 78. Moderna Nucleic Acid Based Gene Therapy Product
Table 79. Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 80. Moderna Recent Development
Table 81. BioNTech Company Detail
Table 82. BioNTech Business Overview
Table 83. BioNTech Nucleic Acid Based Gene Therapy Product
Table 84. BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 85. BioNTech Recent Development
Table 86. Nutcracker Therapeutics Company Detail
Table 87. Nutcracker Therapeutics Business Overview
Table 88. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product
Table 89. Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 90. Nutcracker Therapeutics Recent Development
Table 91. Deep Genomics Company Detail
Table 92. Deep Genomics Business Overview
Table 93. Deep Genomics Nucleic Acid Based Gene Therapy Product
Table 94. Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 95. Deep Genomics Recent Development
Table 96. Sirnaomics Company Detail
Table 97. Sirnaomics Business Overview
Table 98. Sirnaomics Nucleic Acid Based Gene Therapy Product
Table 99. Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 100. Sirnaomics Recent Development
Table 101. Laronde Company Detail
Table 102. Laronde Business Overview
Table 103. Laronde Nucleic Acid Based Gene Therapy Product
Table 104. Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 105. Laronde Recent Development
Table 106. Abogen Biosciences Company Detail
Table 107. Abogen Biosciences Business Overview
Table 108. Abogen Biosciences Nucleic Acid Based Gene Therapy Product
Table 109. Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2019-2024) & (US$ Million)
Table 110. Abogen Biosciences Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Based Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nucleic Acid Based Gene Therapy Market Share by Type: 2023 VS 2030
Figure 3. Anti-Sence and Anti-Gene Features
Figure 4. Short Inhibitory Sequences Features
Figure 5. Gene Transfer Therapy Features
Figure 6. Nucleoside Analogs Features
Figure 7. Ribozymes Features
Figure 8. Aptamers Features
Figure 9. Others Features
Figure 10. Global Nucleic Acid Based Gene Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Nucleic Acid Based Gene Therapy Market Share by Application: 2023 VS 2030
Figure 12. Hospitals and Clinics Case Studies
Figure 13. Academic and Research Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Nucleic Acid Based Gene Therapy Report Years Considered
Figure 16. Global Nucleic Acid Based Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Nucleic Acid Based Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Nucleic Acid Based Gene Therapy Market Share by Region: 2023 VS 2030
Figure 19. Global Nucleic Acid Based Gene Therapy Market Share by Players in 2023
Figure 20. Global Top Nucleic Acid Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid Based Gene Therapy Revenue in 2023
Figure 22. North America Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Nucleic Acid Based Gene Therapy Market Share by Country (2019-2030)
Figure 24. United States Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Nucleic Acid Based Gene Therapy Market Share by Country (2019-2030)
Figure 28. Germany Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Nucleic Acid Based Gene Therapy Market Share by Region (2019-2030)
Figure 36. China Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Nucleic Acid Based Gene Therapy Market Share by Country (2019-2030)
Figure 44. Mexico Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Nucleic Acid Based Gene Therapy Market Share by Country (2019-2030)
Figure 48. Turkey Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Wave Life Sciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 51. Imugene Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 52. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 53. Alnylam Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 54. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 55. Moderna Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 56. BioNTech Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 57. Nutcracker Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 58. Deep Genomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 59. Sirnaomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 60. Laronde Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 61. Abogen Biosciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock